Cuba assures encouraging results for its first COVID-19 vaccine candidate

HAVANA, Cuba, Nov 2 (ACN) The Finlay Institute of Vaccines (IFV), the leading institution in the development of vaccines in Cuba, assured Monday on Twitter the encouraging preliminary results of the first Cuban vaccine candidate against COVID-19, named Sovereign 01.

The Institute specified there were not observed adverse reactions or serious effects, although studies continue to see if there are really antibodies, as it is expected.
In late August, the clinical trial of the first Cuban vaccine candidate against the novel coronavirus SARS-CoV-2 began.
For her part, Dagmar Garcia Rivera, IFV research director, expressed in the same social media that today begins the phase I clinical trials of the second Cuban vaccine candidate called Soberana 2, the only combined vaccine project against this pandemic, after the approval of the Center for State Control of Drugs, Equipment and Medical Devices (CECMED).